Leila Mazdai

Ms. Leila Mazdai

University of Ferrara, Ferrara, Emilia-Romagna, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
MFMatteo Fabbri
Matteo Fabbri
LALetizia Alfieri
Letizia Alfieri
Leila MazdaiLeila Mazdai
Leila Mazdai
PFPaolo Frisoni
Paolo Frisoni
RGRosa Maria Gaudio
Rosa Maria Gaudio
Margherita NeriMargherita Neri
Margherita Neri
In the last few years, predicting externally visible characteristics (EVCs) by adopting informative DNA molecular markers has become a method in forensic genetics that has increased its value, giving rise to an interesting field called “Forensic DNA Phenotyping” (FDP). The most meaningful forensic applications of EVCs prediction are those in which, having only a DNA sample isolated from highly decomposed remains, it is essential to reconstruct the physical appearance of a person. Through this approach, we set out to evaluate 20 skeletal remains of Italian provenance in order to associate them with as many cases of missing persons as possible. To achieve the intended goal, in this work we applied the HIrisPlex-S multiplex system through the conventional short tandem repeats (STR) method to confirm the expected identity of subjects by evaluating phenotypic features. To investigate the reliability and accuracy of the DNA-based EVCs prediction, pictures of the cases were compared as they were available to researchers. Results showed an overall prediction accuracy greater than 90% for all three phenotypic features—iris, hair, and skin colour—at a probability threshold of 0.7. The experimental analysis showed inconclusive results in only two cases; this is probably due to the characteristics of subjects who had an intermediate eye and hair colour, for which the DNA-based system needs to improve the prediction accuracy.

13 June 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
Leila MazdaiLeila Mazdai
Leila Mazdai
MFMatteo Fabbri
Matteo Fabbri
Micaela TirriMicaela Tirri
Micaela Tirri
GCGiorgia Corli
Giorgia Corli
RARaffaella Arfè
Raffaella Arfè
Matteo MartiMatteo Marti
Matteo Marti
In the recent decade, numerous new psychoactive substances (NPSs) have been added to the illicit drug market. These are synthetized to mimic the effects of classic drugs of abuse (i.e., cannabis, cocaine, etc.), with the purpose of bypassing substance legislations and increasing the pharmacotoxicological effects. To date, research into the acute pharmacological effects of new NPSs is ongoing and necessary in order to provide an appropriate contribution to public health. In fact, multiple examples of NPS-related acute intoxication and mortality have been recorded in the literature. Accordingly, several in vitro and in vivo studies have investigated the pharmacotoxicological profiles of these compounds, revealing that they can cause adverse effects involving various organ systems (i.e., cardiovascular, respiratory effects) and highlighting their potential increased consumption risks. In this sense, NPSs should be regarded as a complex issue that requires continuous monitoring. Moreover, knowledge of long-term NPS effects is lacking. Because genetic and environmental variables may impact NPS responses, epigenetics may aid in understanding the processes behind the harmful events induced by long-term NPS usage. Taken together, “pharmacoepigenomics” may provide a new field of combined study on genetic differences and epigenetic changes in drug reactions that might be predictive in forensic implications.

15 March 2023 in American Journal of Hematology
Verified
Journal Article
Closed access
VBVeronica Bordoni
Veronica Bordoni
MCMaddalena Casale
Maddalena Casale
VPValeria Maria Pinto
Valeria Maria Pinto
RCRita Carsetti
Rita Carsetti
BGBarbara Gianesin
Barbara Gianesin
CAChiara Agrati
Chiara Agrati